In early 2023, the National Cancer Institute (NCI) in partnership with the U.S. Department of Health and Human Services (HHS) released the National Cancer Plan, a guide the nation’s efforts against cancer. The Plan provides a framework for collaboration to reduce cancer mortality rates in the United States by at least 50% over the next 25 years and to end cancer as we know it.
The National Association for Proton Therapy (NAPT) proudly announces the submission of a comprehensive letter to the President’s Cancer Panel, advisors to the President on the National Cancer Program. This letter serves as the proton industry’s response to an appeal for input to ensure that the rich landscape of cancer care innovation is informing the National Cancer Plan, an effort central to the mission of the White House Cancer Moonshot Initiative
NAPT’s letter mirrors the priorities outlined in the National Cancer Plan and underscores the proton industry’s commitment to pushing the boundaries of cancer care and expanding equitable access to life-saving cancer treatment. The letter serves as a vital contribution to enrich the dialogue surrounding the future of cancer care.
Visit the NAPT Resource Center to download a copy of the letter.
Thank you so much for sharing about the efforts of the National Association for Proton Therapy and the work you are doing to reduce the impact of prior authorization on cancer patients’ access to proton therapy. Closely aligned with the National Cancer Plan goals, your organization’s actions are inspirational and speak to the important role that everyone plays in accelerating progress against cancer. We will take this into consideration as we draft our next report. We may also highlight your efforts in the next coming months in our social media messaging.
Response from the President’s Cancer Panel
